Pharma
GeneDx pushes for faster rare disease diagnosis
Genomic testing could diagnose rare diseases within weeks, but misconceptions are slowing progress, GeneDx CEO says.
Genomic testing could diagnose rare diseases within weeks, but misconceptions are slowing progress, GeneDx CEO says.
Developers can customize or build on top of these pretrained, healthcare-specific models.
A look at the ways the drugmaker has applied digital twin technology in its clinical studies.
From alternative models of care to making sense of new data, here’s what experts are seeing for next year.
From GLP-1s to AI, leaders share their thoughts.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.